K-numberK253459
Device nameOPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001)
ApplicantABBOTT MEDICAL
Product codeNQQ
Device classClass II
Decision dateApr 24, 2026
DecisionSubstantially Equivalent
Regulation892.1560
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The OPTIS Mobile Next and OPTIS Integrated Next are ultrasonic imaging systems that perform optical coherence tomography (OCT) of coronary arteries using a compatible Dragonfly imaging catheter. They are intended for imaging in patients undergoing transluminal interventional procedures and compute and display physiological parameters including Resting Full-cycle Ratio (RFR), Fractional Flow Reserve (FFR), and Pd/Pa measurements to assess coronary lesion severity.

Technological characteristics

Ultreon 3.0 Software builds upon the predicate Ultreon 1.0 by adding artificial intelligence-based automated lipid detection, AI-based enhancements for angio co-registration, lumen detection, guide catheter detection, and stent detection, fast pullback for faster OCT image acquisition, and cloud connectivity for future software updates. All changes are limited to software only and do not raise new questions of safety or effectiveness.

Test standards cited

ISO 13485:2016 (quality management system), IEC 62304:2015 (medical device software lifecycle), and ISO 14971:2019 (risk management). Software verification and validation testing confirmed the software meets design and user requirements suitable for clinical use.

Substantial equivalence argument

The subject device is substantially equivalent to the predicate OPTIS Next Imaging Systems with Ultreon 1.0 Software (K210458) in terms of intended use, indications for use, operational characteristics, fundamental design, and technological characteristics. Software changes do not raise new safety or effectiveness questions, and comprehensive non-clinical testing, machine learning validation, and risk assessment all demonstrate safe performance as intended, with all performance testing meeting pre-defined acceptance criteria.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →